| Q49951185 | A landscape of germline mutations in a cohort of inherited bone marrow failure patients |
| Q96771745 | ABO incompatibile graft management in pediatric transplantation |
| Q38721768 | Allele-level HLA matching for umbilical cord blood transplantation for non-malignant diseases in children: a retrospective analysis. |
| Q33430004 | Allogeneic hematopoietic stem cell transplantation for inherited bone marrow failure syndromes |
| Q43407730 | Allogeneic hematopoietic stem cell transplantation in Fanconi anemia: the European Group for Blood and Marrow Transplantation experience |
| Q31048572 | Assessment of cord blood unit characteristics on the day of transplant: comparison with data issued by cord blood banks |
| Q44977717 | Binding of thymoglobulin to natural killer cells leads to cell activation and interferon-gamma production |
| Q41879104 | Broad-range PCR-electrospray ionization mass spectrometry for detection and typing of adenovirus and other opportunistic viruses in stem cell transplant patients |
| Q45271778 | Characterization of cord blood natural killer cells: implications for transplantation and neonatal infections |
| Q35119306 | Cohort Profile: the French childhood cancer survivor study for leukaemia (LEA Cohort). |
| Q40569623 | Continuous infusion of ceftazidime in the empiric treatment of febrile neutropenic children with cancer. |
| Q98205278 | Correction: ABO incompatibile graft management in pediatric transplantation |
| Q89811300 | Correction: Supportive care during pediatric hematopoietic stem cell transplantation: beyond infectious diseases. A report from workshops on supportive care of the Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow |
| Q48149034 | Design of the DREPAGREFFE trial: A prospective controlled multicenter study evaluating the benefit of genoidentical hematopoietic stem cell transplantation over chronic transfusion in sickle cell anemia children detected to be at risk of stroke by t |
| Q46401136 | Efficacy of fractionated gemtuzumab ozogamicin combined with cytarabine in advanced childhood myeloid leukaemia |
| Q38382681 | Evaluation of a New Device for Simplifying and Standardizing Stool Sample Preparation for Viral Molecular Testing with Limited Hands-On Time |
| Q47209362 | Follow-up of post-transplant minimal residual disease and chimerism in childhood lymphoblastic leukaemia: 90 d to react. |
| Q34427584 | Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation |
| Q45948328 | GSTA1 diplotypes affect busulfan clearance and toxicity in children undergoing allogeneic hematopoietic stem cell transplantation: a multicenter study. |
| Q38104135 | Hematopoietic stem cell transplantation in SCD. |
| Q33558770 | Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel |
| Q34496583 | Hepatic Veno-Occlusive Disease after Hematopoietic Stem Cell Transplantation: Risk Factors and Stratification, Prophylaxis, and Treatment |
| Q44028608 | Impact of addition of maintenance therapy to intensive induction and consolidation chemotherapy for childhood acute myeloblastic leukemia: results of a prospective randomized trial, LAME 89/91. Leucámie Aiqüe Myéloïde Enfant. |
| Q43969312 | Interaction between methotrexate and ciprofloxacin |
| Q40957134 | Juvenile myelomonocytic leukemia displays mutations in components of the RAS pathway and the PRC2 network. |
| Q55638215 | Late effects after hematopoietic stem cell transplantation for β-thalassemia major: the French national experience. |
| Q37237908 | Late thyroid complications in survivors of childhood acute leukemia. An L.E.A. study |
| Q54465299 | Limited efficacy and tolerance of imatinib mesylate in steroid-refractory sclerodermatous chronic GVHD. |
| Q38629971 | Long Term Outcomes of Cord Blood Transplantation From an HLA-Identical Sibling for Patients with Bone Marrow Failure Disorders: a Report From Eurocord, Cord Blood Committee (CBC-CTIWP) and Severe Aplastic Anemia Working Party (SAAWP) of the European |
| Q33822049 | Metabolic syndrome in long-term survivors of childhood acute leukemia treated without hematopoietic stem cell transplantation: an L.E.A. study |
| Q90590362 | Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?-A multicenter EBMT-PDWP study |
| Q48232467 | Ontogeny of human mucosal-associated invariant T cells and related T cell subsets |
| Q50875591 | Outcome of patients activating an unrelated donor search for severe acquired aplastic anemia. |
| Q47387346 | Outcome of relapse after allogeneic HSCT in children with ALL enrolled in the ALL-SCT 2003/2007 trial |
| Q49709768 | Preservation/congelation of hematopoietic stem cell grafts in a pediatric context: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) |
| Q47551124 | Prevalence and characteristics of metabolic syndrome in adults from the French childhood leukemia survivors' cohort: A comparison with controls from the French population |
| Q42226854 | Relationship between cytomegalovirus (CMV) reactivation, CMV-driven immunity, overall immune recovery and graft-versus-leukaemia effect in children |
| Q45258357 | Second induction in pediatric patients with recurrent acute lymphoid leukemia using DFCI-ALL protocols |
| Q40411281 | Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation |
| Q40788902 | Single- vs double-unit cord blood transplantation for children and young adults with acute leukemia or myelodysplastic syndrome. |
| Q40726021 | Specific T cells for the treatment of cytomegalovirus and/or adenovirus in the context of hematopoietic stem cell transplantation |
| Q89583779 | Supportive care during pediatric hematopoietic stem cell transplantation: beyond infectious diseases. A report from workshops on supportive care of the Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantat |
| Q33456341 | T-cell therapy using a bank of EBV-specific cytotoxic T cells: lessons from a phase I/II feasibility and safety study |
| Q47676439 | The Impact of Donor Type on Long-Term Health Status and Quality of Life after Allogeneic Hematopoietic Stem Cell Transplantation for Childhood Acute Leukemia: A Leucémie de l'Enfant et de L'Adolescent Study |
| Q98205283 | The impact of donor type on the outcome of pediatric patients with very high risk acute lymphoblastic leukemia. A study of the ALL SCT 2003 BFM-SG and 2007-BFM-International SG |
| Q91991543 | Transplantation in Children and Adolescents with Acute Lymphoblastic Leukemia from a Matched Donor versus an HLA-Identical Sibling: Is the Outcome Comparable? Results from the International BFM ALL SCT 2007 Study |
| Q37216480 | Unrelated alternative donor transplantation for severe acquired aplastic anemia: a study from the French Society of Bone Marrow Transplantation and Cell Therapies and the EBMT Severe Aplastic Anemia Working Party |